Advanced Biomed Inc. (NASDAQ:ADVB) Sees Large Increase in Short Interest

Advanced Biomed Inc. (NASDAQ:ADVB) saw a significant growth in short interest in the month of June. As of June 15th, there was short interest totaling 8,876 shares, a growth of 356.3% from the May 31st total of 1,945 shares. Based on an average trading volume of 35,930 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.7% of the shares of the stock are sold short.

Advanced Biomed Trading Down 10.0%

ADVB stock opened at $4.49 on Friday. The business has a 50 day moving average of $4.83. The stock has a market cap of $7.41 million, a PE ratio of 0.93 and a beta of 0.68. Advanced Biomed has a one year low of $3.61 and a one year high of $18.20.

Advanced Biomed (NASDAQ:ADVB) last posted its quarterly earnings data on Friday, May 15th. The company reported ($0.38) earnings per share for the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised shares of Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has an average rating of “Sell”.

About Advanced Biomed

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.